WALTHAM, Mass., April 30, 2025 /PRNewswire/ -- Q32 Bio Inc. (QTTB) ("Q32 Bio"), a clinical stage biotechnology company focused on developing innovative therapies for alopecia areata (AA) and other ...
MIDDLETON, Mass., Sept. 22, 2025 /PRNewswire/ -- MavriX Bio, a clinical-stage biotechnology company focused on the development of transformative genetic therapies for Angelman syndrome (AS), today ...
IDS Worldwide wants its Bio-Track Identification Card and software to be part of the proposed immigration solution announced recently by President Bush. To make it happen, the company has dispatched ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback